ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: For example, Pan, Miao, and Chen (2018) demonstrated that germacrone inhibited MDR1 expression and subsequently decreased the adriamycin resistance of chronic myelogenous leukemia cells.